Abnormalities
Rare Disease·MeSH: Congenital Abnormalities
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| lenalidomide | Mylan II B.V. (MYL) |
Preclinical(1)
| Drug | Company |
|---|---|
| breastcheck | Odyssey Health, Inc. (ODYY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Abnormalities?
BioSniper tracks 2 drugs in development for Abnormalities across 2 companies.
How many clinical trials target Abnormalities?
There are 2 clinical trials targeting Abnormalities tracked by BioSniper.
Deep-dive into Abnormalities
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis